Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate.
Protein Expr Purif. 2022 Feb;190:106003. doi: 10.1016/j.pep.2021.106003. Epub 2021 Oct 21.
Protein Expr Purif. 2022.
PMID: 34688919
Free PMC article.
Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate.
Chen WH, Nyon MP, Poongavanam MV, Liu Z, Biter AB, Kundu RT, Strych U, Hotez PJ, Bottazzi ME.
Chen WH, et al. Among authors: kundu rt.
J Pharm Sci. 2020 May;109(5):1673-1680. doi: 10.1016/j.xphs.2020.02.004. Epub 2020 Feb 15.
J Pharm Sci. 2020.
PMID: 32070701
Free PMC article.
Item in Clipboard
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis.
Liu Z, Kundu R, Damena S, Biter AB, Nyon MP, Chen WH, Zhan B, Strych U, Hotez PJ, Bottazzi ME.
Liu Z, et al.
Protein Expr Purif. 2021 Jan;177:105750. doi: 10.1016/j.pep.2020.105750. Epub 2020 Sep 10.
Protein Expr Purif. 2021.
PMID: 32920041
Item in Clipboard
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.
Chen WH, Wei J, Kundu RT, Adhikari R, Liu Z, Lee J, Versteeg L, Poveda C, Keegan B, Villar MJ, de Araujo Leao AC, Rivera JA, Gillespie PM, Pollet J, Strych U, Zhan B, Hotez PJ, Bottazzi ME.
Chen WH, et al. Among authors: kundu rt.
Biochim Biophys Acta Gen Subj. 2021 Jun;1865(6):129893. doi: 10.1016/j.bbagen.2021.129893. Epub 2021 Mar 14.
Biochim Biophys Acta Gen Subj. 2021.
PMID: 33731300
Free PMC article.
Item in Clipboard
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1.
Lee J, Liu Z, Chen WH, Wei J, Kundu R, Adhikari R, Rivera JA, Gillespie PM, Strych U, Zhan B, Hotez PJ, Bottazzi ME.
Lee J, et al.
Appl Microbiol Biotechnol. 2021 May;105(10):4153-4165. doi: 10.1007/s00253-021-11281-3. Epub 2021 May 7.
Appl Microbiol Biotechnol. 2021.
PMID: 33959781
Free PMC article.
Item in Clipboard
Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells.
Poveda C, Leão AC, Mancino C, Taraballi F, Chen YL, Adhikari R, Villar MJ, Kundu R, Nguyen DM, Versteeg L, Strych U, Hotez PJ, Bottazzi ME, Pollet J, Jones KM.
Poveda C, et al.
Curr Res Immunol. 2023 Jul 20;4:100066. doi: 10.1016/j.crimmu.2023.100066. eCollection 2023.
Curr Res Immunol. 2023.
PMID: 37534309
Free PMC article.
Item in Clipboard
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2.
Thimmiraju SR, Adhikari R, Villar MJ, Lee J, Liu Z, Kundu R, Chen YL, Sharma S, Ghei K, Keegan B, Versteeg L, Gillespie PM, Ciciriello A, Islam NY, Poveda C, Uzcategui N, Chen WH, Kimata JT, Zhan B, Strych U, Bottazzi ME, Hotez PJ, Pollet J.
Thimmiraju SR, et al.
Vaccines (Basel). 2023 Oct 1;11(10):1557. doi: 10.3390/vaccines11101557.
Vaccines (Basel). 2023.
PMID: 37896960
Free PMC article.
Item in Clipboard
Cite
Cite